[ACRS] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
18-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- -93.71%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 6,761 6,482 4,227 10,091 1,683 0 0 -
PBT -90,865 -51,336 -113,542 -132,738 -70,353 -48,079 -20,563 28.07%
Tax 23,416 -182 29,308 2,676 -1,830 -120 -90 -
NP -114,281 -51,154 -142,850 -132,738 -68,523 -48,079 -20,563 33.05%
Tax Rate - - - - - - - -
Total Cost 121,042 57,636 147,077 142,829 70,206 48,079 20,563 34.33%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -1,690.30 -789.17 -3,379.47 -1,315.41 -4,071.48 0.00 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -2.01 -1.20 -3.46 -4.03 -2.44 -2.25 -3.37 -8.24%
EPS Diluted -2.01 -1.20 -3.46 -4.03 -2.44 -2.25 -3.37 -8.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.